Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pragya Shukla
Observed name:
P Shukla
Institution:
Thermo Fisher Scientific (Canada)
Observed institution:
Thermo Fisher Scientific (Canada)
ORCID:
0000-0001-9372-5630
Observed ORCID:
0000-0001-9372-5630
OpenAlex ID:
A5136440492
Transportability of tislelizumab trial outcomes from RATIONALE-315, RATIONALE-303, and RATIONALE-312 to the European population in early-stage non-small cell lung cancer (NSCLC), advanced NSCLC and extensive-stage small cell lung cancer (ES-SCLC)
2026
·
Francesco Passiglia
, Eugenia Priedane
, et al.
·
Future Oncology
Transportability of tislelizumab trial outcomes from RATIONALE-315, RATIONALE-303, and RATIONALE-312 to the European population in early-stage non-small cell lung cancer (NSCLC), advanced NSCLC and extensive-stage small cell lung cancer (ES-SCLC)
2026
·
Francesco Passiglia
, Eugenia Priedane
, et al.
·
Figshare
C103-14 Predicting Long-Term Survival Benefit of Nerandomilast in Patients With Idiopathic Pulmonary Fibrosis
2026
·
T M Maher
, P Pimple
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Show more works
View as search
Works count:
3
Citation count:
H-index:
I10-index:
Year
Topic
Type